Work

A randomized phase II study of ixabepilone (Ix) or mitoxantrone and prednisone (MP) in patients with taxane (T)-resistant hormone refractory prostate cancer (HRPC)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.4566

Authors: J. E. Rosenberg, W. K. Kelly, M. D. Michaelson, G. Wilding, M. Hussain, M. Gross, E. J. Small

Institutions: Memorial Sloan Kettering Cancer Center, University of Wisconsin–Madison, University of California, San Francisco, University of Michigan

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591358879

Cites:

Cited by: 17

Related to: 10